Jeffrey Bernstein Application PackageBernstein Jeffrey N
Last Name First Name Middle Initial
5050 Alton Road Miami Beach,
Home Address City
Florida 33140
State Zip Code
305-986-4032305-585-5250
HomeWork
antivenom@aol.com
Email Address
305-986-4032
Cellular
Miami
Business Address
1611 NW 12th Ave
City
Florida
State
33136
Zip Code
Jackson Memorial Hospital
Occupation:Business Name:
Attending Physician
Please list your preferences in order of ranking [1] first choice [2] second choice, and [3] third choice. Please note
that only three (3) choices will be observed by the City Clerk’s Office. (Regular Boards of City)
Choice 1:
Choice 2:
Choice 3:
Health Advisory Committee
BOARD AND COMMITTEE
APPLICATION FORM
Note:If applying for the At-Large position of the Historic Preservation Board, please answer the below
questions:
Have you ever resided in one of the City's Historic Districts for at least one year?Yes
No Address in City Historic District submitted.
Professional License
License Number Issuance Date Expire Date
Jeffrey Bernstein ME0064824 11/9/2023 1/31/2026
Note:If you are seeking appointment to a professional seat (e.g. attorney, architect, etc.), you must attach a copy of
your currently effective corresponding professional license.
Pursuant to City Code section 2-22(4) a, b and c: Members of Agencies, Boards, and Committees shall be
affiliated with the city. This requirement shall be fulfilled in the following ways:
YesResident of the City for a minimum of six (6) months:
Demonstrate an ownership interest in a business established in the City for a minimum of six (6) months:No
AFFILIATION WITH THE CITY OF MIAMI BEACH
a.
● I am resident of:Middle Beach
Or
b.
"Ownership Interest" shall mean the ownership of ten percent (10%) or more (including the ownership of 10%
or more of the outstanding capital stock) in a business.
"Business" shall mean any sole proprietorship, sponsorship, corporation, limited liability company, or other
entity or business association.
c.Full-time employee of such a business (for a minimum of six months); and I am based in an office or
other location of the business that is physically located in Miami Beach (for a minimum of six months):No
Notwithstanding the requirements set forth herein, the qualified full-time employee of a business must be
approved by a 4/7th vote of the Mayor and City Commission.
NOTE: Members of Agencies, Boards, and Committees shall be required to demonstrate compliance with the
City affiliation requirements of section 2-22 (4) a ,b or c of the Miami Beach City Code by executing an affidavit,
stipulating that they have met one or more of said affiliation requirements. The original affidavit shall be filled with
the Office of the City Clerk prior to being sworn in as a member.
Or
No● Have you ever been convicted of a felony:If yes, please explain in detail:
● Do you currently have a violation(s) of City of Miami Beach codes:No If yes, please explain in detail:
● Do you currently owe the City of Miami Beach any money:No If yes, please explain in detail:
● Are you currently serving on any City Boards or Committees:No If yes, which board?
● Are you presently a registered lobbyist with the City of Miami Beach?No
● I am applying for an appointment because I have special abilities, knowledge and experience. Please list below:
Director of the Florida Poison Control Center in Miami and Attending Physician at Jackson Memorial Hospital
Emergency Care Center since Jan 1997.
NOTE: IF APPOINTED, YOU WILL BE REQUIRED TO FOLLOW CERTAIN LAWS THAT APPLY TO CITY
BOARD/COMMITTEE MEMBERS. THESE LAWS INCLUDE, BUT ARE NOT LIMITED TO:
o Prohibition from directly or indirectly lobbying city personnel (Miami Beach City Code section 2-459).
o Prohibition from contracting with the city (Miami-Dade County Code section 2-11.1).
o Prohibition from lobbying before board/committee you have served on for period of one year after leaving office
(Miami Beach Code section 2-26)
o Requirement to disclose certain financial interests and gifts (Miami-Dade County Code section 2-11.1).
o Sunshine Law - Florida's Government-in-the-Sunshine Law was enacted in 1967. Today, the Sunshine Law
regarding open government can be found in Chapter 286 of the Florida Statutes. These statutes establish a basic
right of access to most meetings of Boards, Commissions, and other governing bodies of state and local
governmental agencies or authorities.
o Voting conflict - Form 8B is for use by any person serving at the county, city, or other local level of government on
an appointed or elected Board, Council, Commission, Authority, or Committee. It applies equality to members of
advisory and non-advisory bodies who are presented with a voting conflict of interest under Section 112.3143.
Florida Statutes.
o Commencing with terms beginning on or after January 1, 2024, and as a condition of applying for appointment to
a City agency, board, or committee, each applicant must voluntarily agree that in the event the applicant files with
the City Clerk a Statement of Candidate formally announcing candidacy for City elective office, such filing with the
City Clerk shall be deemed a tender of resignation from the City agency, board or committee, and the member's
automatic resignation shall thereby immediately create a vacancy in the agency, board, or committee.
o If an appointee is engaged to provide services, for compensation, to either (1) a candidate for City elected office,
or (2) a political committee or electioneering communications organization expending funds for or against
candidates for City elected office, such engagement shall be deemed a tender of resignation from such City
agency, board, or committee. (Miami Beach City Code Section 2-22)
● In what organization(s) in the City of Miami Beach do you currently hold membership in?
No Organization Information Submitted.
● List the address of all properties owned or in which you have an interest within the City of Miami Beach:
Property
Home
If so, which department and title?No● Are you now employed by the City of Miami Beach:
● Pursuant to City Code Section 2-25 (b) and 2-448:
Do you have a parent, spouse, child, brother, or sister who is employed by the City of Miami Beach?No
If "Yes", identify person(s) and department(s):
No relative's information submitted.
BOARD & COMMITTEE FINANCIAL ACKNOWLEDGEMENT STATEMENT
Acknowledgement of fines/suspension for Board/Committee Members for failure to comply with
Miami-Dade County Financial Disclosure Code Section 2-11.1(i)(2)
I understand that no later than July 1, of each year all members of Boards and Committees of the City of Miami
Beach, including those of a purely advisory nature, are required to comply with Miami-Dade County Financial
Disclosure Requirements.
One of the following forms must be filled with the City Clerk of Miami Beach, 1700 Convention Center Drive,
Miami Beach, Florida, no later than 12:00 noon of July 1, of each year:
1. A "Source of Income Statement;" or
2. A Copy of your latest Federal Income Tax Return.
Members of the Planning Board and the Board of Adjustment must electronically file a “Statement of Financial
Interests (Form 1)¹” directly with the Florida Commission on Ethics.
Failure to file one of these forms, pursuant to the Miami-Dade County Code, may subject the person to a fine of no
more than $500, 60 days in jail, or both.
Acknowledgment to Comply with Miami Beach Code of Ordinances Sec. 2-22 (23)
I understand that commencing with terms beginning on or after January 1, 2024, and as a condition of applying for
appointment to a City agency, board, or committee, I voluntarily agree that in the event I file with the City Clerk a
Statement of Candidate formally announcing candidacy for City elective office, such filing with the City Clerk shall be
deemed a tender of resignation from the City agency, board, or committee.
Acknowledgment to Comply with Miami Beach Code of Ordinances Sec. 2-22 (24)
I understand that if I am engaged to provide services, for compensation, to either (1) a candidate for City elected
office, or (2) a political committee or electioneering communications organization expending funds for or against
candidates for City elected office, such engagement shall be deemed a tender of resignation from the City agency,
board, or committee.
_____________________________
¹ Members of the Planning Board and Board of Adjustment will be notified directly by the State of Florida, pursuant
to F.S. §112.3145(1)(a), to file a Statement of Financial Interests (Form 1) with the Miami-Dade County Supervisor of
Elections by 12:00 noon, July 1. Planning Board and Board of Adjustment members who file their Form 1 with the
County Supervisor of Elections automatically satisfy the County’s financial disclosure requirement as a Miami Beach
City Board/Committee member and need not file an additional form with the Office of the City Clerk. However,
compliance with the County disclosure requirement does not satisfy the State requirement.
DIVERSITY STATISTICS REPORT
The following information is voluntary and has no bearing on your consideration for appointment. It is being asked to
comply with City diversity reporting requirements.
WhiteRace/Ethnic Categories
What is your race?
No details providedOther Description:
Gender:Male
Are you Spanish/Hispanic/ Latino? Mark the "No" box if not Spanish / Hispanic /
Latino.
No
Physically Challenged:No
UNDER PENALTIES OF PERJURY, I DECLARE THAT I HAVE READ THE FOREGOING APPLICATION AND
THAT THE FACTS STATED IN IT ARE TRUE. ADDITIONALLY, I AGREE AND ACKNOWLEDGE THAT ANY
FALSE STATEMENTS OR FALSE INFORMATION SUBMITTED AS PART OF THIS APPLICATION SHALL BE
A BASIS FOR MY REMOVAL FROM A CITY BOARD OR COMMITTEE. I HAVE RECEIVED, READ AND WILL
ABIDE BY CHAPTER 2, ARTICLE VII, OF THE MIAMI BEACH CITY CODE, ENTITLED “STANDARDS OF
CONDUCT FOR CITY OFFICERS, EMPLOYEES AND AGENCY MEMBERS” AND ALL OTHER APPLICABLE
CITY, COUNTY, AND/OR STATE LAWS AND STATUTES ACCORDINGLY.
I Jeffrey Bernstein agreed to the following terms on 1/13/2025 4:21:21 PM
Received in the City Clerk's Office by:
Name of Deputy Clerk Control No. Date
Board and Committee Application Checklist: Please ensure you have provided all information before applying or
reapplying to any Board and Committee.
YES
YES
YES
YES
I have answered all questions fully.
I have uploaded a current resume, photograph, and a copy of any applicable professional license.
I have completed and attached the Board & Committee Financial Acknowledgment Statement.
I have completed and attached the Diversity Statistics Report.
If you have any questions, please contact the Office of the City Clerk via email: BC@miamibeachfl.gov or
telephone: 305.673.7411
Note: Florida Statutes 119.071: The role of the Office of the City Clerk is to receive and maintain forms filed as
public records. If your home address, telephone numbers, and/or photograph are exempt from disclosure and you
do not wish your home address, telephone numbers, and/or photograph to be made public, please:
1) Use your office or other address for your mailing address;
2) Use your office or other telephone number for your contact number; and
3) Do not attach a photograph.
YES I voluntarily agree to the resignation from the City agency, board, or committee, if I file a Statement
of Candidate for a City Elective Office (1).
(1) I understand that commencing with terms beginning on or after January 1, 2024, and as a condition of applying for
appointment to a City agency, board, or committee, I must voluntarily agree that in the event I file with the City Clerk a
Statement of Candidate formally announcing candidacy for City elective office, such filing with the City Clerk shall be deemed
a tender of resignation from the City agency, board, or committee.
YES I understand that (2).
(2) If am engaged to provide services, for compensation, to either (1) a candidate for City elected office, or (2) a political
committee or electioneering communications organization expending funds for or against candidates for City elected office,
such engagement shall be deemed a tender of resignation from the City agency, board, or committee.
JEFFREY N. BERNSTEIN, MD
CURRICULUM VITAE
December 2024
PERSONAL
NAME: Jeffrey N. Bernstein, MD
HOME PHONE: (305) 986-4032
OFFICE PHONE: (305) 585-5250
WORK ADDRESS: Florida Poison Information Center
Miami Transplant Institute 1st floor
1801 NW 9th Ave, suite 100
Miami, FL 33136
CURRENT ACADEMIC RANK: Voluntary Associate Professor of Pediatrics and Medicine
PRIMARY DEPARTMENT: Florida Poison and Drug Information Center / Emergency Medicine
JOINT APPOINTMENT: Division of Emergency Medicine (Medicine)
CITIZENSHIP: U.S.A.
HIGHER EDUCATION
INSTITUTIONAL: Emergency Medicine Foundation/Eli Lilly & Company
Research Fellowship in Medical Toxicology The
University of Arizona - University Medical Center,
Tucson, Arizona July 1992- June 1993
NIH Clinical Pharmacology/Medical Toxicology
Fellowship The University of Arizona –
University Medical Center, Tucson, Arizona
July 1991- June 1992
Emergency Medicine Residency, The University of
Arizona - University Medical Center, Tucson,
Arizona - July 1988- June 1991
Rutgers Medical School - University of Medicine &
Dentistry of New Jersey, Camden, New Jersey
Graduate, May 1988, Doctor of Medicine
University of Guadalajara School of Medicine,
Guadalajara, Mexico July 1982- June 1986
Western Maryland College, Westminster, Maryland
Graduate, 1982; Bachelor of Arts, Biology
(WMC is now known as MeDaniel College)
CERTIFICATION, LICENSURE:
Diplomate - Medical Toxicology Sub-Board of ABEM
(January 31, 1995), recertified 12/2004, 12/2014, 12/2024
Diplomate - American Board of Emergency Medicine
910287 (Original certificate: May 26, 1992; Recertification 12/ 2002 and 12/2012, 12/2022)
Diplomate – American Board of Clinical Pharmacology, October 14, 2005 certificate #05107
Florida Board of Medicine unrestricted license 64824 (August 1993)
Arizona Medical License unrestricted license 19668 (September 21, 1990)
North Carolina Medical License unrestricted license 2013-01078 (June 7, 2013)
DEA Certification (November 1, 1990)
Diplomate - National Board of Medical Examiners (July 1989)
Advanced Hazardous Materials Life Support instructor
BLS, ACLS, ATLS, PALS, AHLS certification
EXPERIENCE
ACADEMIC:
Voluntary Associate Professor, University of Miami Departments of Pediatrics and Medicine
Current appointment
Clinical Assistant Professor, Nova Southeast University Department of Emergency Medicine, December
2024
Clinical Assistant Professor, University of South Florida Department of Internal Medicine,
February 1, 1995 – January 1997
Core Teaching Faculty Emergency Medicine, Jackson Memorial Hospital
June 2003 to present
HOSPITAL APPOINTMENTS:
NON-ACADEMIC:
Medical Director, Florida Poison Information Center – Miami, December 15, 1996 – Present
Attending physician Emergency Department, Jackson Memorial Hospital, January 15, 1997 –
Present
Medical Director, FlDOH Covid hotline/Vaccine ADE hotline FPICN/Miami March 2020 – present
Medical Director, National Marine Envenomation Hotline, December 15, 1996-2012
Medical Director, Florida State Teratogen Information Service, January 1, 2004 to present
Grant Medical Director, EMS regional Toxicology Training Program, Tampa Florida 1995 to
August, 2000.
Director, Acute and Critical Care Toxicology, The Emergency Associates for Medicine –
Tampa General Hospital September 1, 1993 - December 15, 1997
Associate Medical Director, The Florida Poison Information Center at The Tampa General
Hospital September 1, 1993 - December 15, 1997
Attending physician Emergency Department The Emergency Associates for Medicine - Tampa General
Hospital September 1, 1993 - December 15, 1997
Attending Physician, Toxic Exposures Clinic – The Emergency Associates for Medicine
September 1, 1993 - December 15, 1997
Medical Review Officer, The Emergency Associates for Medicine - Tampa General Hospital
September 1, 1993 - December 15, 1997
Attending physician Emergency Department, El Dorado Hospital, July 1991 - July 1993
Attending physician Emergency Department, Kino Community Hospital, July 1991 - July 1993
Part-time Emergency Physician, Marcus Lawrence Hospital, Cottonwood, Arizona, January
1991 - June 1991
Part-time Emergency Physician, Gila General Hospital, Globe, Arizona, December 1990 – June1991
PUBLICATIONS
BOOKS AND MONOGRAPHS:
Armando Bevelacqua, Richard Stilp, Florida Special Incident Hazardous Materials Medical Protocols. Basic
and Advanced Life Support Hazardous Materials Medical Protocols (Including Operational K9 Protocols)
Sept. 2018
Mehruba Anwar, Jeffrey Bernstein North American Coral Snakes Toxinology. Clinical Toxinology Edited by
Gopalakrishnakone P. Volume Clinical Toxinology in Australia, Europe, and America. Volume Editors:
Steven Seifert, Denise V. Tamborgi, Carl-Wilhelm Vogel.
Jeffrey Bernstein, North American Coral Snakes: Springer International Publishing AG 2017
J. Brent et al. (eds.), Critical Care Toxicology Diagnosis and Management of the Critically Poisoned Patient
2nd ed,
Jeffrey Bernstein, Luke Yip, Marine Envenomations: Blue Ringed Octopus (Hapalochlaena spp) in Clinical
Decision Support: Clinical Toxicology, edited by Cantor R, Marraffa J and Stork C. 2016. Decision Support
in Medicine, LLC. Wilmington, DE
Jeffrey Bernstein, Luke Yip, Marine Envenomations: Cnidaria: Jellyfish (scyphozoan), Man-o-war
(hydrozoa) Corals (hydrozoa), anemone (anthozoa), box jellyfish (Cubozoa, Chironex, C fleckeri), Irukandji
jellyfish (Cubozoa, Carukia, C barnesi) in Clinical Decision Support: Clinical Toxicology, edited by Cantor
R, Marraffa J and Stork C. 2016. Decision Support in Medicine, LLC. Wilmington, DE
Jeffrey Bernstein, Luke Yip, Marine Envenomations: Sea lice (sea bather’s eruption, Linuche unguiculata) in
Clinical Decision Support: Clinical Toxicology, edited by Cantor R, Marraffa J and Stork C. 2016. Decision
Support in Medicine, LLC. Wilmington, DE
Jeffrey Bernstein, Luke Yip, Marine Envenomations: Cone snails in Clinical Decision Support: Clinical
Toxicology, edited by Cantor R, Marraffa J and Stork C. 2016. Decision Support in Medicine, LLC.
Wilmington, DE
Jeffrey Bernstein, Luke Yip, Marine Envenomations: Sea Snake (Hydrophiidae and Laticaudinae) in Clinical
Decision Support: Clinical Toxicology, edited by Cantor R, Marraffa J and Stork C. 2016. Decision Support
in Medicine, LLC. Wilmington, DE
Jeffrey Bernstein, Luke Yip, Marine Envenomations: Sea urchin (Echinoderm) in Clinical Decision Support:
Clinical Toxicology, edited by Cantor R, Marraffa J and Stork C. 2016. Decision Support in Medicine, LLC.
Wilmington, DE
Jeffrey Bernstein, Luke Yip, Marine Envenomations: Stingray in Clinical Decision Support: Clinical
Toxicology, edited by Cantor R, Marraffa J and Stork C. 2016. Decision Support in Medicine, LLC.
Wilmington, DE
Jeffrey Bernstein, Luke Yip, Marine Envenomations: Stonefishes (Synanceja), lionfishes (Pterois), and
scorpionfishes (Scorpaena) in Clinical Decision Support: Clinical Toxicology, edited by Cantor R, Marraffa J
and Stork C. 2016. Decision Support in Medicine, LLC. Wilmington, DE
Bernstein, J, Inglesby, G, Weisman, R, Advanced Disaster Medical Response Manual for Providers Briggs
and Brinsfield 2nd Ed ., Environmental Module, Cine-Med publishing, Inc, 2004
Bernstein J. Challenger Toxicology [computer program]. (Toxicology) Challenger Corporation, 2003.
Approximately 450 questions with explanations, 22 hours CME given by University of Miami School of
Medicine
Florida Regional Common EMS protocols second edition: Toxicology/Hazardous Materials Exposure, Jones
and Bartlett Publishers, 2011
Florida Regional Common EMS protocols 2004: Toxicology and Hazardous materials Exposure, Jones and
Bartlett Publishers, July 2004
South Florida Common EMS protocols 2001: Author and Reviewer
Bernstein, J, Coral Snake envenomation, Critical Care Toxicology: The Diagnosis and
Management of the Critically Poisoned Patient. Brent J et al. Mosby-Ha, 2005
Bernstein, J, Drugs of Abuse, Medical Toxicology Richard C. Dart, 3rd edition, December 2003
Bernstein, JN, Antivenom (Scorpion and Spider), In: Goldfrank’s Toxicologic Emergencies,
Goldfrank, Flomenbaum, Lewin, Howland, Hoffman, Nelson, 8th ed., McGraw Hill, 1623-1628, 2006
Bernstein, JN, Antivenom (Scorpion and Spider), In: Goldfrank’s Toxicologic Emergencies, Goldfrank,
Flomenbaum, Lewin, Howland, Hoffman, Nelson, 7th ed., McGraw Hill, 1589-1591, 2002
Bernstein, JN, Snakebite, Conns Current Therapy 2001, Rakel and Bope, W.B. Saunders Company, 1176 –
1179, 2001
Bernstein, JN, Scorpion and Spider Antivenom, In: Goldfrank’s Toxicologic Emergencies, Goldfrank,
Flomenbaum, Lewin, Weisman, Howland, Hoffman, 6th ed., Appleton and Lange, 1635-1637, 1998
JURIED OR REFEREED JOURNAL ARTICLES OR EXHIBITIONS:
Ballesteros A, McElroy N, Totapally B, Bernstein J, Successful Management of Aluminum Phosphide
Poisoning in a Pediatric Patient, Poster presented at NACCT 2024 Denver Colorado
Andrew I. Stolbach et al. ACMT Position Statement: End the Use of the Term “Excited Delerium” Journal of
Medical Toxicology (July 2003) 19:310-312
McKena, O, Bernstein, J, Gerona, R, et al. Renal failure after ingestion of lysergic acid diethylamide sold as
“magic mushroom” candy bar" has been accepted for a Poster Presentation at NACCT 2023 Montreal Ca
C. Raciti, M. Blanzaco and J. Bernstein, Death associated with ingestion of starfruit (Averrhoa carambola) in
a patient with chronic kidney disease, American Journal of Emergency Medicine (2023),
https://doi.org/10.1016/ j.ajem.2023.06.043
C. Raciti, L. Weber, K. Muschler, J. Bernstein, Epidemiology of Cnidarian Stings reported to three statewide
US poison centers, Poster presentations NACCT 2023 Montreal Ca
M. Ness-Cochinwala MD 1,2, J.S. Proaño MD1,2, J. Bernstein M3,4,5, P. Martinez MD1,2, H. Ladd, MD1,2, B.
Totapally MD1,2 A case of lethal diquat poisoning in a toddler, JEM 5-2021.
Julissa M. Sarmiento, Avinash Gogineni, Jeffrey N. Bernstein, Alcohol/Illicit Substance Use in Fatal
Motorcycle Crashes, Journal of Surgical Research, Vol 256, Dec 2020, Pages 243-250
Andrew Calzadilla, Amit Badiye, Ali Ghodsizad, Jeffrey Bernstein, Michael Campos, Mehdi Mirsaeidi, A
Young Woman with Bradycardia and Hypotension, Ann Am Thorac Soc, Vol 15, No 9, pp 1092-1095, Sep
2018
Preston RA, Arciniegas R, DeGraff S, Materson BJ, Bernstein J, Afshartous D. Outcomes of minority
patients with Very Severe Hypertension (≥220/≥120 mm Hg). J Hypertens 2019 Feb;37(2):415-425
Melissa A. Friedman, Mercedes Fernandez, Lorraine C. Backer An Updated Review of Ciguatera Fish
Poisoning: Clinical, Epidemiological, Environmental, and Public Health Management, Marine Drugs, 2017,
15, 72
Seifert, C, Abo, B, Bernstein, J, Florida antivenin bank to Miami Dade venom response bureau: the history of
a unique antivenom bank and venom response team, Toxicon, Volume 117, July 2016, page 103
Wood, A, Schauben, J, Thundiyil, J, et.al., Review of Eastern coral snake (Micrurus fulvius fulvius)
exposures managed by the Florida Poison Information Center Network 1998-2010, Clinical Toxicology,
September-October 2013, Bol. 51, No. 8: pages 783-788
Lewis Younger C, Bernstein J, Schauben J., Critical shortage of antivenom is impacting patient care, 17th
World Congress for the Society on Toxinology, Honolulu, Hawaii, July 8-13, 2012
Fleming LE, Backer L, Kirkpatrick B, Reich A, Hollenbeck J, Nierenberg K, Stephan W, Friedman M,
Weisman R, Bernstein J, Jerez E, Baden D., Occupational and Environmental Factors in Neurological
Disease: Harmful Algal Bloom Toxins Occupational and Environmental Factors in Neurological Disease
October 31, 2012 San Francisco, California
Lavonas EJ, Ruha A-M, Banner W, Bebarta V, Bernstein JN, Bush SP, Kerns WP, Richardson WH, Seifert
SA, Tanen DA, Curry SC, Dart RC. Unified treatment algorithm for the management of crotaline snakebite
in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med 2011.
J Bernstein, Clinical and Demographic aspects of Coral Snake envenomation in Florida, Abstracts of the
Coral Snake Antivenom Conference, January 28, 2009 J Med Toxicology, Volume 5, Number 4 December
2009
Daniel S. Chertow, E. Tan, S. Maslanka, J. Schulte, E. Bresnitz, R. Weisman, J. Bernstein , S. Marcus, S.
Kumar, J. Malecki, J. Sobel, C. Braden, Botulism in 4 Adults Following cosmetic Injections With an
unlicensed, highly concentrated Botulinum preparation, JAMA, November 22/29, 2006; 296,(20) 3476-2479
Robyn S Weisman, Jeffrey N Bernstein, Richard S Weisman, Inadequate anaesthesia in lethal injection for
execution, Lancet 2005;366:1074
Daniel S. Chertow, E. Tan, S. Maslanka, J. Schulte, E. Bresnitz, R. Weisman, J. Bernstein , S. Marcus, S.
Kumar, J. Malecki, J. Sobel, C. Braden. Botulism In Four Adults Related To Cosmetic Injections of
Unlicensed Botulinum Toxin Type A Florida, 2004; presentation at Center for Disease Control – EIS
conference, April 11, 2005
Melissa A. Friedman, Patricia Arena, Bonnie Levin, Lora Fleming, Richard Weisman, Jeff Bernstein, Kathleen
Schrank, Donna Blythe, Lorraine Backer & Andy Reich Neuropsychological consequences of ciguatera fish
poisoning: Preliminary results of a longitudinal study accepted for presentation as part of the Division 40
program at the American Psychological Association Convention, to be held in Washington, D.C, August 18-
21, 2005
Hughes, AA, Dart, RC, RADARS system Poison Center Group; Seasons of Abuse? Temporal Trends of
Prescription Opioids, Journal of Toxicology/Clinical Toxicology, 2004, Vol. 42, No. 5, pp. 762-763
Diego Ize-Ludlow, Sean Ragone, Isaac S. Bruck, Jeffrey N. Bernstein, Michael Duchowny, and Barbara M
Garcia Pena, Neurotoxicities in Infants Seen With the Consumption of Star Anise Tea, Pediatrics, Vol.114
No. 5, November 2004, pp. e653-e656
Ize-Ludlow Diego, Ragone Sean, Bernstein Jeffrey N, Bruck Isaac S, Duchowny Michael, Pena Barbara,
Chemical composition of Chinese Star Anise (Illicium Verum) and neurotoxicity in infants, JAMA,
2004;291:562-563
Hughes AA, Bogdan GM, Dart RC. Bernstein JN, et al., Comparative rates of Oxycontin abuse: anecdotal
highs, J. Toxicology, Clin Tox., vol. 41, no. 5, 2003 abstract 252, page 746, presented as poster at NACCT,
September 2003
Allen, S., Bernstein J., Weisman, R., Ragone, S., The use of Poison Centers for surveillance and response to
bioterrorism events, J. Toxicology, Clin. Tox., vol. 40, no. 5, 2002 abstract 105, page 642, presented as
poster at NACCT, September 2002
Allen, S., Bernstein J., Weisman, R., Ragone, S., Poison Information Center: The command center for the
decontamination facility of mass urban casualty events, J. Toxicology, Clin. Tox., vol. 40, no. 5, 2002
abstract 170, page 671, presented as poster at NACCT, September 2002
Ragone, S. Bernstein, J., Lew, E., Weisman, R., Fatal Aluminum Phosphide Ingestion, J. Toxicology, Clin.
Tox., vol. 40, no. 5, 2002 abstract 216, page 690, presented as poster at NACCT, September 2002
Pancorbo, D, Weisman, R, Bernstein, J, Eastern Coral Snake bite to the tongue with facial swelling, accepted
for presentation at NACCT, September 2000
Martinez, E, Bernstein, J, Weisman, R, Pilot study of treatment of Jellyfish stings, abstract J. Clinical
Toxicology July 2000, accepted for presentation at NACCT, September, 2000
T. McNutt, J. Chambers-Emerson, G. Gaar, S. Normann, J. Bernstein, Use of a Beta Adrenergic Antagonist
Equipotency Calculation To Assess Toxicity In Pediatric Ingestions, Presented as platform session at
NACCT meeting St. Louis Mo. Sept 1997 (Winner of AAPCC research award)
Bernstein JN, Dart RC, Garcia R, Najari Z, Egen N, Efficacy Of Antiscorpion (Centruroides Exilicauda)
Fab In A Mouse Model. Accepted for Poster presentation Sept. 1994 at AACT international conference Salt
Lake City, Utah
Bernstein JN, McNally, JT, Boyer, L, Magnetic Resonance Imaging of Methanol Induced Optic Nerve
Toxicity, A case report, Poster presented Sept. 1993 at AACT international conference NYC
Bernstein JN, Dart RC, Hardy D, Natural History Of Envenomation By The Twin Spotted Rattlesnake
(Crotalus p. pricei) A case report, Abstract submitted to AACT, Poster presented Sept. 1992 at AACT
international conference Tampa FL.
Burgess JL, Bernstein JN, Hurlbut K, Aldicarb Poisoning: A Case Report With Prolonged Cholinesterase
Inhibition And Improvement After Pralidoxime Administration; Arch Intern Med, Vol 154 Jan 24, 1994,
Poster presented at the AACT Tampa Florida, Sept. 1992.
Hurlbut KM, Bernstein JN, Burgess JL, Dart RC, Sullivan JB, Herring AM, Arteola L, Bell's Palsy and
Frontal Lobe Functional Deficit from Ethylene Oxide Exposure, Abstract submitted to AACT, Poster
presented Sept. 1992.
OTHER WORKS, PUBLICATIONS AND ABSTRACTS:
Stephan, W, Bernstein JN, Weisman, RS, IN-TOX South Florida, News of the Florida Poison Information
Center – Miami, Cannabis Edibles and Kids, Serious Pediatric Poisonings, Boric Acid Ingestions, Summer
2023
Stephan, W, Bernstein JN, Weisman, RS, IN-TOX South Florida, News of the Florida Poison Information
Center – Miami, Sodium Nitrite/Abortifacients, Summer 2022
Stephan, W, Bernstein JN, Weisman, RS, IN-TOX South Florida, News of the Florida Poison Information
Center – Miami, Fomepizole for APAP/Riot Control Agents, Winter 2022
Stephan, W, Bernstein JN, Weisman, RS, IN-TOX South Florida, News of the Florida Poison Information
Center – Miami, Vaccine ADE’s/Cisatracurium alert/Measuring Snake Bite, Winter 2021
Sarmiento, JM, Gogineni, A, Mulder M, Bernstein JN, Lineen EB, Byers PM, Alcohol/Illicit Substance Use
and Riding Behavior Among motorcycle Crash Fatalities, Academic Surgical Congress Feb 5, 2020
Bernstein, JN, Stephan, W, IN-TOX South Florida, News of the Florida Poison Information Center – Miami,
Poison Cures from the Kitchen/Meth Makes a Comeback, Winter 2020
Bernstein, JN, Weisman RS, IN-TOX South Florida, News of the Florida Poison Information Center –
Miami, Self Harm/Synthetic Cathinones, Summer 2018
Bernstein, JN, Weisman RS, IN-TOX South Florida, News of the Florida Poison Information Center –
Miami, Naloxone Notes/Contacting Your Poison Center, Spring 2017
Bernstein, JN, Weisman RS, IN-TOX South Florida, News of the Florida Poison Information Center –
Miami, Training on Poison/Heroin and Fentanyl, Winter 2017
Bernstein, JN, Weisman RS, IN-TOX South Florida, News of the Florida Poison Information Center –
Miami, New Florida Laws for Overdose/Naled, Fall 2016
Bernstein, JN, Weisman RS, IN-TOX South Florida, News of the Florida Poison Information Center –
Miami, Single Dose Laundry Packets/Blue Green Algae, Summer 2016
Sollee, DA, Bernstein, JN, Got Flakka?, EM Pulse, Journal of the Florida College of Emergency Physicians,
2016, 23(1): 32-33
Lewis CR, Bernstein JN, Schauben J, Critical Shortage of Coral Snake Antivenom is Impacting Patient Care.
Platform presentation for the 17th World Congress of the International Society on Toxinology Animal, Plant
and Microbial Toxins & Venom Week 2012, 4th International Scientific Symposium on All Things
Venomous Honolulu, Hawaii, USA, July 9, 2012
Weisman, RS, Bernstein JN, Lyman LS, Aragones PA, The Availability of a New Antidote:
Hydroxocobalamin, EM Pulse, Journal of the Florida College of Emergency Physicians, 2007, 12(1): 19-20
Dreyfuss, L, Bernstein JN, Weisman RS, Introduction to Pharmacogenomics, EM Pulse, Journal of the
Florida College of Emergency Physicians, 2006, 11(1): 16-18
Scheraga DA, Weisman RS, Bernstein JN, An Appreciation for Teratogens Part I, EM Pulse, Journal of the
Florida College of Emergency Physicians, 2005, 10(1): 30-31
Scheraga DA, Weisman RS, Bernstein JN, An Appreciation for Teratogens Part II, EM Pulse, Journal of the
Florida College of Emergency Physicians, 2005, 10(2): 24-27
Robinson, L, Bernstein JN, Sollee, DR, Mercury Poisoning, EM Pulse, Journal of the Florida College of
Emergency Physicians, 2004, 9(5): 29-30
Bruce Quinn, Jeffrey Bernstein, Richard Weisman, Herbs and Your Heart, Ephedra, Oleander, and Chan Su,
EM Pulse, Journal of the Florida College of Emergency Physicians, Vol. 9 No. 2 April 2004
Memon, AM, Bernstein, JN, Weisman, RS: Cyanide. EM Pulse, Journal of the Florida College of
Emergency Physicians, 2004; 9(1):14-15.
Ventzek, A, Valeron, N, Weisman, R, Bernstein J: Isopropanol Intoxication: A Case Report: EM Pulse,
Volume 8, No 1, January/February 2003 p 14-15
Weisman, RS, Bernstein JN, Ciguatera Fish Poisoning, EM Pulse, Vol. 7 No. 1, December / January 2002
p 31-33
Bernstein, J, Allen,S, Weisman,R, Poisonous Plants of Florida, EMPulse, Journal of the Florida College of
Emergency Physicians, p32-34, Vol8.no.3, May/June 2003
Trepka, MJ, Bernstein J, Weisman J, MMWR report Lead Poisoning in three Haitian Children Associated
With Car Battery Recycling, in press
Weisman R, Thompson V, Bernstein J, Antihistamines, Allergy Season At The Florida Poison Information
Network, Florida Pharmacy Today, May 1997, 18-23
Bernstein, JN, Poisonous Plants of Florida, Journal of Florida Medical Association, Vol. 8, no. 11, 1994
PROFESSIONAL
FUNDED RESEARCH PERFORMED:
Principal Investigator, RADARS 8 project, surveillance of opioid abuse, Denver Health and Hospital
Authority, Jan 2003 to present, $40,000 per year, ongoing
RADARS PUBLICATIONS:
Bailey JE, Barton PL, Lezotte D, Lowenstein SR, Dart RC. The effect of FDA approval of a generic
competitor to OxyContin® (Oxycodone HCl Controlled-Release) tablets on the abuse of oxycodone. Drug
and Alcohol Dependence. 2006;84:182-187.
Bailey JE, Campagna E, Dart RC, Reporting for the RADARS System Poison Center Group. The
underrecognized toll of prescription opioid abuse on young children. Annals of Emergency Medicine.
2009;53:419-424.
Cicero TJ, Dart RC, Inciardi JA, Woody GE, Schnoll S, Munoz A. The development of a comprehensive
risk-management program for prescription opioid analgesics: Researched Abuse, Diversion and Addiction-
Related Surveillance (RADARS®). Pain Medicine. 2007;8(2),157-170.
Cicero TJ, Ellis MS, Paradis A, Ortbal Z. Determinants of Fentanyl and other potent μ opioid agonist misuse
in opioid-dependent individuals. Pharmacoepidemiology and Drug Safety. 2010;19:1-7.
Cicero TJ, Ellis MS, Paradis A, Ortbal Z. The role of key informants and direct patient interviews in
epidemiological studies of substance abuse. Pharmacoepidemiology and Drug Safety. 2010;In Press.
Cicero TJ, Ellis MS, Surratt HL. Effect of abuse-deterrent formulation of OxyContin. New England Journal
of Medicine. 2012;367(2):187-189.
Dart RC, Cicero TJ, Surratt HL, Rosenblum A, Bartelson BB, Adams EH. Assessment of the abuse of
tapentadol immediate release: The first 24 months. Journal of Opioid Management. In press.
Cicero TJ, Inciardi JA. Diversion and abuse of methadone prescribed for pain management. Journal of the
American Medical Association. 2005;293(3):297-298.
Cicero TJ, Inciardi JA, Munoz A. Trends of abuse in OxyContin® and other opioid analgesics in the United
States: 2002-2004. The Journal of Pain. 2005;6(10):662-672.
Cicero TJ, Inciardi JA, Surratt HL. Trends in the use and abuse of branded and generic extended release
oxycodone and fentanyl products in the United States. Drug and Alcohol Dependence. 2007;91:115-120.
Cicero T, Inciardi JA, Surratt H, Horbay G, Bordman J, Forster I. Characteristics of prescription opioid
abuse in the United States and Canada. Canadian Journal of Addiction Medicine. 2010;In Press.
Cicero TJ, Surratt H, Inciardi JA, Munoz A. Relationship between therapeutic use and abuse of opioid
analgesics in rural, suburban and urban locations in the United States. Pharmacoepidemiology and Drug
Safety. 2007;16:827-840.
Dasgupta N, Bailey JE, Cicero T, Inciardi JA, Parrino M, Rosenblum A, Dart RC. Post-marketing
surveillance of methadone and buprenorphine in the United States. Pain Medicine. 2010;In Press.
Hayes BD, Klein-Schwartz W, Doyon S. Toxicity of buprenorphine overdoses in children. Pediatrics.
2008;121:782-786.
Hughes AA, Bogdan GM, Dart RC, Reporting for the Researched Abuse Diversion and Addiction-Related
Surveillance (RADARS®) System Poison Center Group. Active surveillance of abused and misused
prescription opioids using poison center data: A pilot study and descriptive comparison. Clinical
Toxicology. 2007;45:144-151.
Inciardi JA, Cicero TJ, Munoz A, Adams EH, Geller A, Senay EC, Woody GE. The diversion of Ultram®,
Ultracet®, and generic tramadol HCl. Journal of Addictive Diseases. 2006;25:53-58.
Inciardi JA, Goode JL. OxyContin® and prescription drug abuse. Consumers’ Research. 2003;(July):17-21.
Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban
community: The results of an ultrarapid assessment. Pain Medicine. 2009;10(3):537-548.
Inciardi JA, Surratt HL, Cicero TJ, Kurtz SP, Martin SS, Parrino MW. The ‘black box’ of prescription drug
diversion. Journal of Addictive Diseases. 2009;28(4):332-347.
Inciardi JA, Surratt HL, Cicero TJ, Rosenblum A, Ahwah C, Bailey JE, Dart RC, Burke JJ. Prescription
drugs purchased through the internet: Who are the end users? Drug and Alcohol Dependence. 2010; 110(1-
2):21-9.
Inciardi JA, Surratt HL, Kurtz SP, Burke JJ. The diversion of prescription drugs by health care workers in
Cincinnati, Ohio. Substance Use and Misuse. 2006;41:255-264.
Inciardi JA, Surratt HL, Lugo Y, Cicero TJ. The diversion of prescription opioid analgesics. Law
Enforcement Executive Forum Journal. 2007;(November):125-141.
Inciardi JA, Surratt HL, Stivers Y, Cicero TJ. FDA approvals of generic drugs: Impact on the diversion of
opioid analgesics with a potential for abuse. Journal of Opioid Management. 2009;5(2) 81-87.
Maxwell JC, McCance-Katz EF. Indicators of buprenorphine and methadone use and abuse: What do we
know? The American Journal on Addictions. 2009;19:73–88.
Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland C, Magura S, Haddox D. Prescription
opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence. 2007;
90:64-71.
Schneider, MF, Bailey, JE, Cicero TJ, Dart RC, Inciardi JA, Parrino M, Munoz A. Integrating nine
prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug
abuse in the United States in 2007. Pharmacoepidemiology and Drug Safety. 2009;18(9):778-90.
Smith MY, Bailey JE, Woody GE, Kleber HD. Abuse of buprenorphine in the United States: 2003 – 2005.
Journal of Addictive Diseases. 2007;26(3):107–111.
Smith MY, Dart RC, Hughes AA, Geller A, Senay EC, Woody GE, Colucci S. Clinician validation of
poison control center intentional exposure cases involving prescription opioids. American Journal of Drug
and Alcohol Abuse. 2006;32:465-478.
Smith MY, Irish W, Wang J, Haddox J, Dart RC. Detecting signals of opioid analgesic abuse: Application
of a spatial mixed effect Poisson regression model using data from a network of poison control centers.
Pharmacoepidemiology and Drug Safety. 2008;17:1050-1059.
Smith MY, Rosenblum A, Parrino M, Haddox JD, Fong C, Colucci S. Validity of self-reported misuse of
prescription opioid analgesics. Substance Use and Misuse. 2010;45:1509-1524.
Smith MY, Schneider MF, Wentz A, Hughes A, Haddox JD, Dart RC. Quantifying morbidity associated
with the abuse and misuse of opioid analgesics: A comparison of two approaches. Clinical Toxicology.
2007;456:23-30.
Spiller H, Bailey JE, Dart RC, Spiller SS. Investigation of temporal changes of abuse and misuse of
prescription opioids. Journal of Addictive Disease. 2010;29:78-83.
Spiller H, Lorenz DJ, Bailey JE, Dart, RC. Epidemiological trends in abuse and misuse of prescription
opioids. Journal of Addictive Diseases. 2009;28:130-136.
RADARS ABSTRACTS:
Bailey JE, Bogdan GM, Dart RC. Adolescent prescription opioid abuse and misuse. The Colorado Public
Health Association Conference. Vail, CO. August, 2006.
Bailey JE, Bogdan GM, Dart RC. Extended release versus immediate release morphine: Differences in abuse
and medical outcomes. North American Congress of Clinical Toxicology Conference. San Francisco, CA.
October, 2006.
Bailey JE, Bogdan GM, Dart RC, Reporting for the RADARS® System Poison Control Centers.
Demographic differences in the misuse and abuse of oxycodone formulations: Poison center surveillance.
The Drug Information Association Conference. Philadelphia, PA. June, 2006.
Bailey JE, Dart RC. Exposures to oxycodone: Demographic differences by formulation. American College
of Emergency Physicians. New Orleans, LA. October, 2006.
Bucher Bartelson B, Severtson SG, Davis JM, Surratt H, Chilcoat H, Coplan P, Green JL, Dart RC. A
comparison of the street price of original and reformulated extended release oxycodone product. International
Association for the Study of Pain Annual Meeting. Madison, WI. August 2012.
Buchholtz C, Reifler LM, Bailey JE, Dart RC. Chewing then swallowing in self reported non-medical opioid
use by college students as reported by the Researched Abuse, Diversion and Addiction-Related Surveillance
(RADARS®) System. The College on Problems of Drug Dependence Annual Meeting. Scottsdale, AZ.
June, 2010.
Buchholtz C, Thomasset C, Bailey JE, Dart RC. Administration routes involved in non-medical use of long-
acting opioids in the RADARS® System College Survey and Poison Center Programs. North American
Congress of Clinical Toxicology Conference. Denver, CO. October, 2010.
Campagna E, Bailey JE, Dart RC. Prescription opioid abuse in urban versus rural communities using
RADARS® System Data. The College on Problems of Drug Dependence Conference. Quebec City,
Canada. June, 2007.
Campagna E, Bailey JE, Dart RC. Fentanyl patch abuse using RADARS® System Poison Center Data.
North American Congress of Clinical Toxicology Conference. New Orleans, LA. October, 2007.
Campagna E, Bailey JE, Dart RC. Detection of prescription opioid abuse/diversion using RADARS®
System Data. The College on Problems of Drug Dependence Annual Meeting. San Juan, PR. June 2008.
Campagna E, Kirtland MN, Bailey JE, Spiller HA, Dart RC. The effectiveness of the Kentucky operation
UNITE (Unlawful Narcotics Investigations, Treatment and Education) as evaluated by RADARS® System
Poison Centers. The American Public Health Association Conference. Washington, DC. November, 2007.
Cleland C, Rosenblum A, Fong C, Parrino M. Prescription opioid abuse predicts first admission into
methadone maintenance treatment. The College on Problems of Drug Dependence Annual Meeting.
Scottsdale, AZ. June, 2010.
Cleland C, Rosenblum A, Fong C, Parrino M, Magura S. Age effects on heroin and prescription opioid
abuse among enrollees into methadone maintenance treatment. The College on Problems of Drug
Dependence. Reno, NV. June, 2009.
Cram LM, Bailey JE, Dart RC. Description of buprenorphine, methadone, hydrocodone and oxycodone
abuse and diversion rates using RADARS® System Data. The College on Problems of Drug Dependence
Conference. Quebec City, Canada. June, 2007.
Dart RC, Adams E, Bucher-Bartelson B, Baker G, Pitner J, Vorsanger G. Tapentadol abuse: the first 18
months. PAINWeek 2012. Las Vegas, NV. September 2012.
Dart RC, Hughes AA, Reporting for the RADARS® System Poison Control Centers. Public health
disparities in rural areas: High rates of prescription opioid abuse? The American Public Health Association
Conference. Philadelphia, PA. December, 2005.
Dart RC, Hughes AA, Smith MY Reporting for the RADARS® System Poison Control Centers. Adolescent
prescription opioid abuse and misuse: Surveillance by Poison Centers. The College on Problems of Drug
Dependence Conference. Scottsdale, AZ. June, 2006.
Dasgupta N, Bailey JE, Dart RC, Funk MJ. Poison center intentional exposure calls predict mortality due to
prescription opioids. The American Public Health Association Conference. Washington, DC. November,
2007.
Davis J, Buchholtz C, Wheat A, Bartelson BB, Dart RC. Predictors of moderate, substantial or severe
problems associated with drug abuse in college students reporting recent opioid use. College on Problems of
Drug Dependence Annual Meeting. Hollywood, FL. June, 2011.
Davis J, Miller H, Winter E, Dart RC. Suicide behaviors with prescription drugs in individuals over 50 years
of age identified by Radars System Poison Center Program. American Public Health Association Annual
Meeting. Washington, DC. October, 2011.
Davis J, Miller H, Winter E, Dart RC. Suicide behaviors with prescription drugs in individuals over 50 years
of age identified by Radars System Poison Center Program. American Public Health Association Annual
Meeting. Washington, DC. October, 2011.
Davis JM, Severtson SG, Bucher Bartelson B, Muñoz A, Schneider MF, Surratt H, Chilcoat H, Coplan P,
Green JL, Dart RC. Reduction In Extended Release (ER) Oxycodone Diversion Rates Following the
Introduction of a Reformulated ER Oxycodone Product. International Association for the Study of Pain
Annual Meeting. Madison, WI. August 2012.
Davis JM, Severtson SG, Bucher Bartelson B, Muñoz A, Schneider MF, Surratt H, Chilcoat H, Coplan P,
Green JL, Dart RC. Reduction In Extended Release (ER) Oxycodone Diversion Rates Following the
Introduction of a Reformulated ER Oxycodone Product. International Association for the Study of Pain
Annual Meeting. Madison, WI. August 2012.
Graham A, Smith MY, Haddox JD, Wright C. Reducing the potential for diversion of prescription opioids:
Tested interventions. The College on Problems of Drug Dependence Conference. Orlando, FL. June, 2005.
Green JL, Dart RC, Bartelson BB. Buprenorphine abuse in the United States: Comparison to methadone
using five surveillance programs simultaneously. European Association of Poisons Centres and Clinical
Toxicologists. Dubrovnik, Croatia. May, 2011.
Haddox JD, Schnoll SH. The standards for risk management plans for high abuse potential medications.
The College on Problems of Drug Dependence Conference. Washington, DC. April, 2005.
Haddox JD, Smith MY, Colucci S, Rosenblum A, Fong C, Maxwell C, Parrino M. Pain as a reason for
seeking admission to methadone treatment. The College on Problems of Drug Dependence Conference.
Scottsdale, AZ. June, 2006.
Hedge MW, Smolinski S, Bailey JE, Dart RC, RADARS System Poison Center Group. Ototoxicity of
prescription opioids. North American Congress of Clinical Toxicology Conference. San Antonio, TX.
September, 2009.
Hughes AA, Bogdan GM, Bond R, Dart RC. Increase in OxyContin® abuse or media hype? North
American Congress of Clinical Toxicology Conference. Palm Springs, CA. September, 2002.
Hughes AA, Bogdan GM, Dart RC. Comparative rates of OxyContin® abuse: Anecdotal highs. North
American Congress of Clinical Toxicology Conference. Chicago, IL. September, 2003.
Hughes AA, Dart RC, Reporting for the RADARS® System Poison Control Centers. Demographic
differences of the misuse and abuse of oxycodone formulations. The Colorado Public Health Association
Conference. Denver, CO. September, 2005.
Hughes AA, Dart RC, Bailey JE, Reporting for the RADARS® System Poison Control Centers. Lick or
stick: The common routes of the misuse and abuse of fentanyl. North American Congress of Clinical
Toxicology Conference. Orlando, FL. September, 2005.
Hughes AA, Dart RC, Reporting for the RADARS® System Poison Control Centers. Prescription drug
abuse epidemic: Surveillance of opioid abuse using poison centers. The American Public Health Association
Conference. Philadelphia, PA. December, 2005.
Hughes AA, Dart RC, Reporting for the RADARS® System Poison Control Centers. Seasons of abuse?
Temporal trends of prescription opioids. North American Congress of Clinical Toxicology Conference.
Seattle, WA. September, 2004.
Hughes AA, Dart RC, Reporting for the RADARS® System Poison Control Centers. Surveillance of the
RADARS® System by poison control centers. The College on Problems of Drug Dependence Conference.
Orlando, FL. June, 2005.
Inciardi JA, Surratt HL. The diversion of prescription opioids in the US. The College on Problems of Drug
Dependence Conference. Scottsdale, AZ. June, 2006.
Inciardi JA, Surratt H, Kurtz SP, Cicero TJ. The diversion of generic prescription drugs. The College on
Problems of Drug Dependence Conference. Quebec City, Canada. June, 2007.
Kirtland MN, Bailey JE, Dart RC. Prescription opioid misuse and abuse: Surveillance by the RADARS®
System Poison Centers. American Pain Society. Washington, DC. May, 2007.
Kirtland MN, Bailey JE, Dart RC. Suicide and gender: Characterization using RADARS® System Poison
Center Data. American Psychiatric Association. Washington, DC. May, 2008.
Kirtland MN, Bailey JE, Dart RC. Prescription opioid associated death rates using RADARS® System Data.
American Academy of Addiction Psychiatry Conference. Boca Raton, FL. December, 2008.
Kirtland MN, Lemon S, Bailey JE, Dart RC. Effectiveness of a poison center intervention on product
coding. North American Congress of Clinical Toxicology Conference. Toronto, Canada. September, 2008.
Kline AT, Smith MY, Fitzgerald JP, Haddox JD, Bailey JE. A comparison of NSDUH results and
RADARS® System Poison Center Network results for the non-medical use of opioid analgesics, 2003-2004.
The College on Problems of Drug Dependence Conference. Quebec City, Canada. June, 2007.
Kline AT, Smith MY, Haddox JD, Rosenblum A, Fong C, Parrino, M, Maxwell C. Abuser-reported sources
of illegally obtained opioid analgesic medications. The College on Problems of Drug Dependence
Conference. Scottsdale, AZ. June, 2006.
Kurtz SP, Surratt HL, Cicero TJ, Ibanez GE, Rosenblum A, Dart RC, Inciardi JA. Internet-based diversion of
prescription opioids. American Academy of Pain Medicine Annual Meeting. Washington, DC. March 2011.
Lindholm A, Varughese S, Rosen S, Sembower M, Ertischek M, St. Jean E, Schnoll S. Innovative use of
multiple surveillance data sources for detection of misuse, abuse and diversion in the Risk Management Plan
(RMP) of stimulant medications used in ADHD. Drug Information Association 2009 Annual Meeting. San
Diego, CA. June, 2009.
Montoya AM, Bailey JE, Dart RC. Current nonmedical prescription drug use among college students:
Analysis of RADARS® System Data. The American Academy of Addiction Psychiatry Conference. Boca
Raton, FL. December, 2008.
Montoya AM, Heltshe SL, Dart RC. Spatial analysis of RADARS® System Data to identify geographic hot
spots of prescription opioid abuse. The College on Problems of Drug Dependence Conference. San Juan,
PR. June, 2008.
Montoya AM, Zolot LM, Bailey JE, Dart RC. Motives for non-medical prescription opioid use among
RADARS® System College Survey respondents–Indication of a substance abuse disorder? The College on
Problems of Drug Dependence Annual Meeting. Reno, NV. June, 2009.
Parrino M, Rosenblum A, Fong C, Maxwell C, Magura S. Distance traveled and cross state commuting
among patients in Opioid Agonist Treatment Programs (OTPs). The College on Problems of Drug
Dependence Annual Meeting. San Juan, PR. June, 2008.
Reifler LM, Droz D, Bartelson BB, Bailey JE, Dart RC. RADARS® System Poison Center opioid abuse and
misuse rates over time in states with and without active prescription monitoring programs. American Public
Health Association Annual Meeting. Denver, CO. November, 2010.
Reifler LM, Droz D, Bartelson BB, Bailey JE, Schnoll, Dart RC, RADARS System Poison Center Group.
Reduction over time in RADARS® System Poison Center opioid abuse/misuse rates associated with
prescription monitoring programs. North American Congress of Clinical Toxicology Conference. Denver,
CO. October, 2010.
Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Haddox JD, Magura S.
Prescription opioid abuse among patients enrolling in methadone maintenance treatment. The College on
Problems of Drug Dependence Conference. Quebec City, Canada. June, 2007.
Schnoll SH, Sembower MA, Shiffman S, Varughese S, Ertischek MD, St. Jean E, Rosen S. Non-medical use
of extended release prescription stimulants: An examination of amphetamine and methylphenidate. The
College on Problems of Drug Dependence Annual Meeting. Scottsdale, AZ. June, 2010.
Senay EC, Geller A, Woody G, Dart RC, Hughes A, Smith MY. Patterns of abuse, dependence and misuse
of prescription opioid analgesics, benzodiazepines and carisoprodol in 7792 calls to poison control centers.
The College on Problems of Drug Dependence Conference. Orlando, FL. June, 2005.
Smith MY, Dart RC, Hughes A, Geller A, Senay EC, Woody G, Colucci S. Clinician validation of poison
control center intentional exposure cases involving prescription opioids. The College on Problems of Drug
Dependence Conference. Orlando, FL. June, 2005.
Smith MY. Measuring rates of nonmedical use - Dimensions and denominators. The College on Problems
of Drug Dependence Conference. Washington, DC. April, 2005.
Smith MY, Irish W, Wang J, Haddox JD, Dart RC. Relative rate of opioid analgesic abuse in communities
in the US. The College on Problems of Drug Dependence Conference. Scottsdale, AZ. June, 2006.
Spaeth AL, Bailey JE, Dart RC. Characterization of buprenorphine abuse using RADARS® System Poison
Center Data. The College on Problems of Drug Dependence Annual Meeting. San Juan, PR. June, 2008.
Spiller HA, Lorenz D, Bailey JE, Dart RC. Epidemiological trends in prescription drug misuse and abuse.
The College on Problems of Drug Dependence Annual Meeting. San Juan, PR. June, 2008.
Spiller HA, Spiller SS, Bailey JE, Dart RC. Does day of week impact prevalence of prescription drug abuse?
The College on Problems of Drug Dependence Annual Meeting. Reno, NV. June, 2009.
Spiller HA, Spiller SS, Bailey JE, Dart RC. Does prescription drug abuse take a holiday? The College on
Problems of Drug Dependence Annual Meeting. Reno, NV. June, 2009.
Sweet LE, Zolot L, Bailey JE, Dart RC. Where do calls come from? Analysis of RADARS® System Opioid
and Stimulant Poison Center (PC) mentions by caller site and intent. North American Congress of Clinical
Toxicology Conference. San Antonio, TX. September, 2009.
Varney SM, Buchanan JA, Lavonas EJ, Campagna EJ, Bailey JE, Dart RC. How opioid-acetaminophen
patients die. North American Congress of Clinical Toxicology Conference. Toronto, Canada. September,
2008.
Varughese S, Rosen S, Ertischek MD, Sembower MA, St. Jean E, Schnoll S. Non-medical use surveillance
and signal identification of Lisdexamfetamine Dimesylate, a pro-drug stimulant for the treatment of ADHD.
American Psychiatric Association Annual Meeting. New Orleans, LA. May, 2010.
Varughese S, Rosen S, Lindholm A, Ertischek MD, Sembower MA, Schnoll S. Non-medical use surveillance
and signal identification of lisdexamfetamine dimesylate, a pro-drug stimulant for the treatment of ADHD.
American Academy of Child and Adolescent Psychiatry Annual Meeting. New York, NY. October, 2010.
Varughese S, Rosen S, Lindholm A, Ertischek MD, Sembower MA, St. Jean E, Schnoll S. Non-medical use
surveillance and signal identification of lisdexamfetamine dimesylate, a pro-drug stimulant for the treatment
of ADHD. Canadian Psychiatric Association. Toronto, Canada. September, 2010.
Zosel AE, Campagna E, Bailey JE, Dart RC. Demographic variables associated with prescription opioid
abuse and diversion detected by the RADARS® System. The College on Problems of Drug Dependence
Annual Meeting. San Juan, PR. June 2008.
Wheat A, Buchholtz C, Davis J, Dart RC. Predictors of severe prescription drug abuse among college
students using the RADARS System College Survey. College on Problems of Drug Dependence Annual
Meeting. Hollywood, FL. June, 2011.
Wheat A, Davis J, Bartelson BB, Buchholtz C, Dart RC. Is drug source a predictor of severity of non-medical
prescription drug use among college students? Do source predictors vary by Gender? American Public Health
Association Annual Meeting. Washington, DC. October, 2011.
Wheat A, Davis J, Bartelson BB, Dart RC. The interaction between gender and severity of prescription drug
abuse among college students on ability to correctly identify photos of recently abused drugs. International
Conference of Pharmacoepidemiology. Chicago, IL. August, 2011.
Winter EJ, Buchholtz C, Davis JM, Severtson SG, Dart RC. Poison center calls for intentional exposures to
opioids are highly correlated with retail availability in the RADARS System Poison Center Program. North
American Congress of Clinical Toxicology Conference. Washington, DC. September 2011.
Zosel A, Bailey JE, Buchholtz C, Ross E, Dart RC. Methadone-associated deaths by formulation as reported
by the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System. The College
on Problems of Drug Dependence Annual Meeting. Scottsdale, AZ. June, 2010.
Zosel AE, Kirtland M, Bailey JE, Dart RC. Characterization of adolescent prescription drug abuse as
reported in RADARS® System Poison Center Data. The College on Problems of Drug Dependence Annual
Meeting. Reno, NV June, 2009.
Emergency Medicine Foundation Research Fellowship Award 1992-1993 for Development And Efficacy of
Antiscorpion Fab Wilderness Medical Society Research Award1992 to 1993 for Purification of Scorpion
Antivenom
EDITORIAL RESPONSIBITIES:
Senior reviewer, Annals of Emergency Medicine; December 1994 to present
Reviewer, Journal of Emergency Medicine March 2007 to present
Assistant editor, Micromedex corp, Jan 2000 to Jan 2010
Reviewer, Clinical Toxicology, September 1999 to present
Reviewer, Southern Medical Journal, 1996 to present
Reviewer, American Journal of Gastroenterology March 15, 2004 to present
Reviewer, Wilderness & Environmental Medicine journal December 2006 to present
Reviewer, Journal of Medical Toxicology June 2011 to present
Reviewer, Pediatrics February 2011 to present
Reviewer, Journal of Intensive Care Medicine July 2017
Reviewer, Journal of the Neurological Sciences May 2019
PROFESSIONAL AND HONORARY ORGANIZATIONS:
Fellow, American College of Medical Toxicology (FACMT)
Fellow, American College of Emergency Physicians (FACEP) discontinued Jan 2024
Fellow, American Academy of Emergency Medicine (FAAEM)
Fellow, American Academy of Clinical Toxicology (FAACT)
American Association of Poison Control Centers
American College of Emergency Physicians - Section of Toxicology
Florida College of Emergency Physicians
American College of Clinical Pharmacology
HONORS AND AWARDS:
Annal of Emergency Medicine Top Peer Reviewer 2007
Annal of Emergency Medicine Top Peer Reviewer 2005
American Academy of Poison Control Center research award 1999
Grant Director, overseer of project for Use of a Beta Adrenergic Antagonist Equipotency Calculation To
Assess Toxicity In Pediatric Ingestions
Emergency Medicine Foundation Research Fellowship Award 1992-1993 for Development
And Efficacy of Antiscorpion Fab
Wilderness Medical Society Research Award 1992 to 1993 for Purification of Scorpion Antivenom
Arizona Disease Control Research Commission, Isolation and 1992 to 1993 efficacy of Antiscorpion Fab,
proposal ID No. 2 – 066
POST DOCTORAL FELLOWSHIPS:
Fellowship in Medical Toxicology/Clinical Pharmacology July 1991-July 1993
OTHER PROFESSIONAL ACTIVITIES:
Medico-legal expert witness 1993-present, various
Advisory board, Therapeutic Antibodies inc., 1992-1996
Advisory board, rare drug therapeutics, 1996- 2003
Advisory board, Savage pharmaceuticals, 1998-2004
Advisory board, Silanes laboratories, 1999-2001
Advisor, National Drug Intelligence Center, 2000-2013
TEACHING
TEACHING SPECIALIZATION:
UM-JMH Residency In Emergency Medicine, Coordinator and Preceptor for ongoing Journal Club July 2016
to present
Core faculty duties, simulation lab, airway, centerline and suturing lab and various didactics for the
Emergency Care Center Teaching Programs
Teaching of Toxicology to University of Miami medical students as part of the Pediatric rotation every
Tuesday afternoon 130pm
Responsible for content and supervision of FPIC/Miami educational outreach program (see addendum)
Responsible for teaching the Toxicology Rotation for: Pediatric residents, Internal Medicine residents,
Medicine/Pediatrics residents, Psychiatry (Addictionology) Emergency Medicine Residents (Nova SE
University/Mt. Sinai) and Pharmacy Students (Nova SE University)
Regularly give Grand Rounds and other teaching lectures throughout JMH / University of Miami including:
Pediatrics, Internal Medicine, Med/Peds, Psychiatry and Mount Sinai Medical Center for Emergency
Medicine and Internal Medicine residencies
Responsible for training and supervision of Specialists in poison information for the Florida Poison and Drug
Information Center/ Miami and responsible for quality of medical advice given out by the center.
Fellowship Director, Florida Poison Information Center/ Miami Toxicology Fellowship program 1997 - 2000
Preceptor, University of Florida, Physicians Assistant program Jan 1996 - December 1996
Instructor, Advanced Pediatric Life Support Course, Sept 1993 – December 1996
THESIS AND DISSERTATION ADVISING/POST DOCTORAL STUDENT SUPERVISION:
Wendy Stephan, MPH CHES: PhD Project in Progress, “Is Hispanic Ethnicity Protective Against
Poisoning”? Member of Advisory Committee Oct 2016 to present
The use of Pyxis data as a source of Adverse Drug Reactions within an Urban teaching hospital, Deborah
Larison, Pharmacy Dept, JMH
Preceptor
The ABCs of PSVT to be presented as post doc project January 2004 Atlanta Ga. Deborah Larison
Pharmacy Dept. JMH
Preceptor
SERVICE
UNIVERSITY COMMITTEE AND ADMINISTRATIVE RESPONSIBILITIES:
Chairman, Medication Safety Subcommittee Jackson August 2000 to present
Memorial Hospital
Pharmacy and Therapeutics committee Jackson Memorial July 2000 to present
Hospital
Formulary Subcommittee, Jackson Health System September 2012 to present
Jackson Hospital System - Clinical Research Review Committee, November 2006 - present
Standing member
ACMT Position Statements & Guidelines Committee September 2022 to present
Executive Patient Safety Committee, JMH hospital December 2004 to 2005
Executive Director Performance Evaluation Committee
American Association of Poison Control Centers 2010-2013
Medical Director Committee, America Association of Poison from inception
Control
Envenomation SIG, American Academy of Clinical Toxicology 2006 – present
Medication Safety Interest Group, American College of Medical 2010 to present
Toxicology
Hazardous drug subcommittee Jackson Memorial Hospital September 2002 to 2006
EMS Training Advisory Board, Medical Simulation Teaching 2001 to 2006
Laboratory
Hospital Incident Commander, Weapons of Mass Destruction 2001 to 2004
program, Jackson Memorial Hospital
Weapons of Mass Destruction Program Co-coordinator, Jackson 2001 to 2004
Memorial Hospital
Weapons of Mass Destruction Training and Education 2001 to 2004
Subcommittee Chairman, JMH
Civic Center Disaster Committee, Member 2001 to 2004
Participant, Environmental Care/ HAZMAT policy meetings May 2000 to 2009
for JMH Statewide Advisory Group on the Chemical/Radiological
Response Plan , Florida Hospital Association December 2005
Bylaws committee, American Assoc. Poison Control Centers Jan 2011
COMMUNITY ACTIVITIES:
Todah Rabah award Miami Beach JCC May 12, 2021
Camp Physician, Camp Judaea Hendersonville, NC July 2013 – present
Africanized Honeybee Interagency Coordination Group July 2006-present
National Poison Center Certification Committee, Member Dec. 2000 to Jan. 2004
Medical Advisor for Miami Fire Rescue (radio supervision of paramedics)
Dade County Disaster Management Committee, participant September 1998
World Health Organization, INTOX project, consultant, 1997 to 2000
American College of Emergency Physicians grassroots initiative
Group Leader 1997 to 2006
Provide interviews for media on behalf of JMH, University of
Miami, and FPDIC 1997 to present
Hazardous Materials Response Committee, Tampa General Jan. 1994 to Dec. 1997
Continuing Emergency Medical Education Committee Tampa
General Hospital Sept. 1993 to Dec. 1996
Medical services provided at the Huichole Indian Center Santiago
Ixcuitla, Tepic, Mexico February 1992
El Coli Clinic; Banda Clinic; Kino Clinic, Guadalajara, Mexico
(provided medical care for underserved rural Mexico) 1982 to 1986